Zhonghua Zhang

Dr. Zhonghua Zhang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ZZZhonghua Zhang
Zhonghua Zhang
XZXiao-ming Zhou
Xiao-ming Zhou
XZXin Zhang
Xin Zhang
Clinically, early brain injury (EBI), which refers to the acute injuries to the whole brain in the phase of the first 72 h following subarachnoid hemorrhage (SAH), is intensely investigated to improve neurological and psychological function. Additionally, it will be meaningful to explore new therapeutic approaches for EBI treatment to improve the prognosis of patients with SAH. To investigate the underlying neuroprotection mechanism in vitro, the Protein tyrosine phosphatase 1B inhibitor (PTP1B-IN-1) was put in primary neurons induced by OxyHb to observe neuroapoptosis, neuroinflammation, and ER stress. Then, one hundred forty male mice were subjected to Experiment two and Experiment three. The mice in the SAH24h + PTP1B-IN-1 group were given an intraperitoneal injection of 5 mg/kg PTP1B-IN-1 30 min before anesthesia. SAH grade, neurological score, brain water content, Western blot, PCR, and Transmission Electron Microscopy (TEM) were performed to observe the underlying neuroprotection mechanism in vivo. Overall, this study suggests that PTP1B-IN-1 could ameliorate neuroapoptosis, neuroinflammation, and ER stress in vitro and in vivo by regulating the IRS-2/AKT signaling pathway, suggesting that PTP1B-IN-1 may be a candidate drug for the treatment of early brain injury after SAH.

18 April 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ZZZhonghua Zhang
Zhonghua Zhang
LZLidong Zhang
Lidong Zhang
XZXiao-ming Zhou
Xiao-ming Zhou
XZXin Zhang
Xin Zhang
The subarachnoid hemorrhage (SAH) is an important cause of death and long-term disability worldwide. As a nicotinamide adenine dinucleotide-dependent deacetylase, silent information regulator 1 (Sirt1) is a multipotent molecule involved in many pathophysiological processes. A growing number of studies have demonstrated that Sirt1 activation may exert positive effects on SAHs by regulating inflammation, oxidative stress, apoptosis, autophagy, and ferroptosis. Thus, Sirt1 agonists may serve as potential therapeutic drugs for SAHs. In this review, we summarized the current state of our knowledge on the relationship between Sirt1 and SAHs and provided an updated overview of the downstream molecules of Sirt1 in SAHs.

8 July 2026 in Cellular Signalling
Verified
Journal Article
Open access
ZZZhonghua Zhang
Zhonghua Zhang
PSPeipei Shen
Peipei Shen
LZLin Zong
Lin Zong
LZLidong Zhang
Lidong Zhang
Aneurysmal subarachnoid hemorrhage (SAH) is a devastating acute hemorrhagic stroke. The communication between the endoplasmic reticulum (ER) and mitochondria, mediated by mitochondria-associated membranes (MAMs), is critical for neuronal homeostasis. This study investigates whether disrupted ER-mitochondrial coupling at MAMs, characterized by altered contact distance and area, contributes to early brain injury (EBI) after SAH by facilitating pathological Ca2+ transfer via the IP3R1/GRP75/VDAC1 complex. We further explore the therapeutic potential of targeting this complex. Primary cortical neurons exposed to oxyhemoglobin (OxyHb) and a mouse model of SAH were employed. The dynamic changes in MAM structure (ER-mitochondria distance, contact length), ER stress, and Ca2+ handling were assessed. Using shRNA-mediated knockdown and lentiviral overexpression of IP3R1, we evaluated its role in modulating MAM integrity, ER stress markers (p-eIF2α, ATF4, CHOP), Ca2+ dynamics, and neuronal apoptosis. SAH induction led to a significant decrease in ER-mitochondria distance and an increase in MAM contact area, concurrent with upregulation of the IP3R1/GRP75/VDAC1 complex. These changes were associated with elevated ER stress and increased cytosolic and mitochondrial Ca2+ levels. Knockdown of IP3R1 rescued the SAH-induced ultrastructural changes at MAMs, attenuated ER stress, and reduced Ca2+ overload, thereby decreasing neuronal apoptosis and alleviating neurological deficits. Conversely, IP3R1 overexpression exacerbated these pathological outcomes. Pathological enhancement of ER-mitochondria coupling via the IP3R1/GRP75/VDAC1 complex is a key driver of Ca2+-mediated neuronal apoptosis in EBI after SAH. Targeted downregulation of IP3R1 represents a promising therapeutic strategy to restore MAM homeostasis and mitigate brain injury.

13 November 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
JZJieping Zhou
Jieping Zhou
LCLiying Cui
Liying Cui
ZZZhonghua Zhang
Zhonghua Zhang
LZLin Zong
Lin Zong
Background: Spinal anesthesia in patients aged ≥80 years is often challenging due to severe degenerative changes of the lumbar spine. The conventional paramedian approach may still encounter difficulties. This study aimed to compare the efficacy and safety of a lateral (modified paramedian) approach with the conventional paramedian approach for spinal anesthesia in patients aged ≥80 years undergoing hip surgery. Methods: This retrospective cohort study was conducted at Jinling Hospital between January 2022 and December 2025. In this retrospective cohort study, 144 patients aged ≥80 years who underwent hip surgery under spinal anesthesia were included. 65 patients (MP group) received the lateral approach, and 79 patients (CP group) received the conventional paramedian approach. A 1:1 propensity score matching (PSM) was performed to balance age, sex, BMI, ASA physical status, and spinal degeneration grade. The primary outcome was the first-attempt success rate. Secondary outcomes included anesthesia-to-surgery time, needle repositioning required, repositioning rate, incidence of complications, and postoperative hospital stay. Results: After PSM, 65 patients remained in each group. Baseline characteristics were well-balanced (all P > 0.05). The first-attempt success rate was higher in the lateral group than in the conventional paramedian group (56.9% vs. 50.8%), but the difference was not statistically significant (OR 1.27, 95% CI 0.62–2.61, P = 0.617). The lateral approach significantly reduced anesthesia-to-surgery time (mean difference –6.40 min, 95% CI –11.32 to –1.48, P = 0.012) and the incidence of postoperative back pain (12.3% vs. 27.7%, OR 0.37, 95% CI 0.15–0.89, P = 0.032). Conclusions: The lateral (modified paramedian) approach was associated with significantly shorter anesthesia-to-surgery time and a lower incidence of postoperative back pain. Although the first-attempt success rate was numerically higher with the lateral approach, the difference did not reach statistical significance, and the current data do not establish its superiority. The lateral approach may serve as a valuable alternative for this vulnerable population, though further prospective evaluation is warranted. As a retrospective single-center study, residual confounding and selection bias cannot be fully excluded.

17 September 2026 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
MXMiaomiao Xu
Miaomiao Xu
LLLiping Li
Liping Li
ZZZhonghua Zhang
Zhonghua Zhang
HHHaixia Huang
Haixia Huang
Transcription factors (TFs) are central regulators of ferroptosis, an iron‑dependent lipid peroxidation‑driven cell death, in diabetic complications. This review synthesizes evidence into an integrated network model in whHIF-1αich a pro‑survival arm (NRF2) and a pro‑ferroptotic arm (HIF‑1α, p53, ATF4) antagonistically control iron metabolism, antioxidant defense, and lipid peroxidation. These TF networks crosstalk with autophagy and apoptosis via ATF4‑CHOP and p53 pathways, and are modulated by epigenetic mechanisms. Targeting these axes with KEAP1‑NRF2 inhibitors, PROTACs, or ncRNA‑based therapies shows promise, but clinical translation faces challenges due to TF pleiotropy, lack of cell‑type specificity, and absence of clinical ferroptosis biomarkers. Graphical Abstract